Please go to Enter Survey and review Ron Allen's talk entitled "New Method and Catheter to Treat Patients Experiencing Kidney Failure." Pre-registration is now open for the August 8th B2DG evening meeting with Anupam Agarwal on "Drug Safety and Pharmacovigilance, the Past, Present and Future." Please go to https://goo.gl/Ek7JGV to Register and pay thru our Paypal link.

The Bio2Device Group (B2DG) is a premier organization for all San Francisco Bay Area professionals in pharmaceutical, biotech, medical device, diagnostics and other life science industry sectors. Weekly programs are designed to keep members up-to-date with industry news, help them explore other industry sectors, and provide networking opportunities with other life science professionals from all industry sectors and corporate functions. The B2DG also hosts a moderated LinkedIn Group to facilitate communication between members.

Our Next Event

Ronald C. Allen, PhD - CEO & President - Chrysalis Medical
07/25/2017 - 8:30am
Sunnyvale City Council Chambers- 456 West Olive Ave., Sunnyvale

Ron will present and discuss a newly developed method to treat Chronic Kidney Failure developed by Chrysalis Medical.

Chrysalis Medical, Inc. is a developer, manufacturer, and marketer of breakthrough, disruptive medical technologies. In concert with university research facilities, physicians, entrepreneurs, and engineers, Chrysalis reviews and evaluates promising medical technologies...

Syndicate content